Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Rigby

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Trends in Immunology|February 25, 2015
RNA degradation in antiviral immunity and autoimmunityRachel E Rigby, Jan Rehwinkel
Nature Reviews. Immunology|June 14, 2020
A versatile mouse model of COVID-19Helene Borrmann, Rachel E Rigby
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 12, 2008
Nucleic acid-mediated inflammatory diseasesRachel E Rigby, Andrea Leitch, Andrew P Jackson
European Journal of Immunology|October 15, 2019
Deoxyguanosine is a TLR7 agonistTamara Davenne, Anne Bridgeman, Rachel E Rigby, et al.
Scientific Reports|May 12, 2019
PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infectionRachel E Rigby, Helen M Wise, Nikki Smith, et al.
EMBO Reports|March 28, 2026
Single-cell analysis of signalling and transcriptional responses to type I interferonsRachel E Rigby, Kevin Rue-Albrecht, Aleksandr Fedorov, et al.
Nature Communications|July 8, 2021
Fractional response analysis reveals logarithmic cytokine responses in cellular populationsKarol Nienałtowski, Rachel E Rigby, Jarosław Walczak, et al.
Immunity|September 15, 2021
Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responsesQiannan Tang, Rachel E Rigby, George R Young, et al.
European Journal of Immunology|March 25, 2018
Infection with a Brazilian isolate of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signalingJonny Hertzog, Antonio Gregorio Dias Junior, Rachel E Rigby, et al.
Cell Reports|May 14, 2020
SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTPTamara Davenne, Jenny Klintman, Sushma Sharma, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Trends in Immunology|February 25, 2015
RNA degradation in antiviral immunity and autoimmunityRachel E Rigby, Jan Rehwinkel
Nature Reviews. Immunology|June 14, 2020
A versatile mouse model of COVID-19Helene Borrmann, Rachel E Rigby
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 12, 2008
Nucleic acid-mediated inflammatory diseasesRachel E Rigby, Andrea Leitch, Andrew P Jackson
European Journal of Immunology|October 15, 2019
Deoxyguanosine is a TLR7 agonistTamara Davenne, Anne Bridgeman, Rachel E Rigby, et al.
Scientific Reports|May 12, 2019
PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infectionRachel E Rigby, Helen M Wise, Nikki Smith, et al.
EMBO Reports|March 28, 2026
Single-cell analysis of signalling and transcriptional responses to type I interferonsRachel E Rigby, Kevin Rue-Albrecht, Aleksandr Fedorov, et al.
Nature Communications|July 8, 2021
Fractional response analysis reveals logarithmic cytokine responses in cellular populationsKarol Nienałtowski, Rachel E Rigby, Jarosław Walczak, et al.
Immunity|September 15, 2021
Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responsesQiannan Tang, Rachel E Rigby, George R Young, et al.
European Journal of Immunology|March 25, 2018
Infection with a Brazilian isolate of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signalingJonny Hertzog, Antonio Gregorio Dias Junior, Rachel E Rigby, et al.
Cell Reports|May 14, 2020
SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTPTamara Davenne, Jenny Klintman, Sushma Sharma, et al.
Pageof 2